Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes

Diabetes, Obesity and Metabolism

Volumn 11, Issue 8, 2009, Pages 819-822

  Mourad, C ^a   Chevalier, S ^a   Morais, J A ^a   Lamarche, M ^a   Gougeon, Rejeanne ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Gastric emptying; Gut hormones; Respiratory quotient; Satiety; Thermic effect of food; Type 2 diabetes mellitus

Indexed keywords

BRANCHED CHAIN AMINO ACID; FRUCTOSAMINE; GHRELIN; GLIBENCLAMIDE; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; METFORMIN; PEPTIDE YY;

ADULT; AREA UNDER THE CURVE; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUNGER; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PROTEIN BLOOD LEVEL; SATIETY; STOMACH EMPTYING; VISUAL ANALOG SCALE; WAIST CIRCUMFERENCE;

AGED; AMINO ACIDS; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIPEPTIDES; FASTING; GASTRIC EMPTYING; GLUCAGON-LIKE PEPTIDE 1; GLYBURIDE; HUMANS; HUNGER; HYPOGLYCEMIC AGENTS; INSULIN; LEPTIN; MALE; METFORMIN; MIDDLE AGED; POSTPRANDIAL PERIOD; SATIATION; THIAZOLIDINEDIONES;

EID: 67649908702     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01044.x     Document Type: Article

References (12)

1. Batterham RL, Bloom SR. The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci 2003; 994: 162-168.
2. Schultes B, Peters A, Hallschmid M et al. Modulation of food intake by glucose in patients with type 2 diabetes. Diabetes Care 2005; 28: 2884-2889.
3. Veldhorst MA, Nieuwenhuizen AG, Hochstenbach-Waelen A et al. Comparison of the effects of a high- and normal-casein breakfast on satiety, 'satiety'hormones, plasma amino acids and subsequent energy intake. Br J Nutr, 2008; 1-9.
4. Lejeune MP, Westerterp KR, Adam TC, Luscombe-Marsh ND, Westerterp-Plantenga MS. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr 2006; 83: 89-94.
5. English PJ, Ashcroft A, Patterson M et al. Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes. Diabetes Metab Res Rev 2007; 23: 299-303.
6. Mannucci E, Pala L, Ciani S et al. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 2005; 48: 1168-1172.
7. Samsom M, Vermeijden JR, Smout AJ et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: A prospective study in unselected diabetic patients. Diabetes Care 2003; 26: 3116-3122.
8. Johansson UB, Eskils J, Adamson U, Elwin CE, Wredling R, Lins PE. A paracetamol-pasta test for assessing gastric emptying in healthy and diabetic subjects. Scand J Clin Lab Invest 2003; 63: 159-166.
9. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord 2000; 24: 38-48.
10. le Roux CW, Batterham RL, Aylwin SJ et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 2006; 147: 3-8.
11. Vilsboll T, Krarup T, Sonne J et al. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003; 88: 2706-2713.
12. Erdmann J, Lippl F, Wagenpfeil S, Schusdziarra V. Differential association of basal and postprandial plasma ghrelin with leptin, insulin, and type 2 diabetes. Diabetes 2005; 54: 1371-1378.